CN Patent

CN115920000A — 补体活性的调节剂

Assigned to UCB Holdings Ltd. · Expires 2023-04-07 · 3y expired

What this patent protects

本发明涉及补体活性的调节剂，具体而言，本发明涉及补体活性的多肽调节剂，包括环状多肽调节剂。包括利用这样的调节剂作为治疗剂的方法。

USPTO Abstract

本发明涉及补体活性的调节剂，具体而言，本发明涉及补体活性的多肽调节剂，包括环状多肽调节剂。包括利用这样的调节剂作为治疗剂的方法。

Drugs covered by this patent

zilucoplan-sodium (ZILUCOPLAN SODIUM)

Patent Metadata

Patent number: CN115920000A
Jurisdiction: CN
Classification: —
Expires: 2023-04-07
Drug substance claim: No
Drug product claim: No
Assignee: UCB Holdings Ltd.
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.